A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Por um escritor misterioso
Descrição
Frontiers NK Cells in a Tug-of-War With Cancer: The Roles of
Prolonged innate immune activation by enzyme-sensitive
A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting
Cancers, Free Full-Text
Microparticles: biogenesis, characteristics and intervention
Future Pharmacology, Free Full-Text
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent
Targeted therapy for non‐small‐cell lung cancer: New insights into
The solute carrier SLC35F2 enables YM155-mediated DNA damage
de
por adulto (o preço varia de acordo com o tamanho do grupo)